Diabetic Painful Neuropathy and Restless Legs Syndrome in Diabetes Sanjay KalraAnu Gupta Editorial Open access 09 February 2018 Pages: 441 - 447
EADSG Guidelines: Insulin Therapy in Diabetes Bahendeka SilverKaushik RamaiyaAnthony Makhoba Guidelines Open access 05 March 2018 Pages: 449 - 492
Diabetes in the Elderly Sanjay KalraSuresh K. Sharma Practical Approach Open access 19 February 2018 Pages: 493 - 500
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes Lori BerardNoreen AntonishynJean-François Yale Practical Approach Open access 23 February 2018 Pages: 501 - 519
Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment Maria J. Peláez-JaramilloAllison A. Cárdenas-MojicaCarlos O. Mendivil Review Open access 06 February 2018 Pages: 521 - 543
Herpes Zoster and Diabetes Mellitus: A Review Marianthi PapagianniSymeon MetallidisKonstantinos Tziomalos Review Open access 08 March 2018 Pages: 545 - 550
Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes Steven P. MarsoElise HardyRobert J. Chilton Original Research Open access 03 February 2018 Pages: 551 - 564
Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States Cheryl NeslusanAnna TeschemakerLien Vo Original Research Open access 06 February 2018 Pages: 565 - 581
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study Sarah J. HallbergAmy L. McKenzieJeff S. Volek Original Research Open access 07 February 2018 Pages: 583 - 612
Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study Sarah J. HallbergAmy L. McKenzieJeff S. Volek Author Correction Open access 05 March 2018 Pages: 613 - 621
Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies Takashi KadowakiKazuyo SasakiYoshiteru Ushirogawa Original Research Open access 12 February 2018 Pages: 623 - 636
Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population Kristina S. BoyeFady T. BotrosMaureen J. Lage Original Research Open access 19 February 2018 Pages: 637 - 650
Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study Jelica Bjekić-MacutTeodora Beljić ŽivkovićRadivoj Kocić Original Research Open access 19 February 2018 Pages: 651 - 662
Author Correction: Clinical Benefit of Basal Insulin Analogue Treatment in Persons with Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study Jelica Bjekić-MacutTeodora Beljić ŽivkovićRadivoj Kocić Author Correction Open access 22 March 2018 Pages: 663 - 663
Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech Republic Denisa Janíčková ŽďárskáMartin HillJan Brož Original Research Open access 19 February 2018 Pages: 665 - 672
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis Yue GaoKe WangBao Liu Original Research Open access 23 February 2018 Pages: 673 - 682
User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors Guido FreckmannNina JendrikeCornelia Haug Original Research Open access 03 March 2018 Pages: 683 - 697
Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial Wei LiFan PingYuxiu Li Original Research Open access 08 March 2018 Pages: 699 - 711
Adherence to Insulin, Emotional Distress, and Trust in Physician Among Patients with Diabetes: A Cross-Sectional Study Lucine HalepianMary Bou SalehLydia Rabbaa Khabbaz Original Research Open access 08 March 2018 Pages: 713 - 726
Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries Martin HaluzikAdam KretowskiNebojsa Lalic Original Research Open access 09 March 2018 Pages: 727 - 741
Factors That Influence Pancreatic Beta Cell Function and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Patients: A Sub-Analysis of the MARCH Trial Yan DuanJia LiuGuang Wang Original Research Open access 09 March 2018 Pages: 743 - 752
Adverse Drug Events Associated with Low-Dose (10 mg) Versus High-Dose (25 mg) Empagliflozin in Patients Treated for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Xia DaiZu-chun LuoFeng Huang Original Research Open access 09 March 2018 Pages: 753 - 770
Insulin Glargine Combined with Oral Antidiabetic Drugs for Asians with Type 2 Diabetes Mellitus: A Pooled Analysis to Identify Predictors of Dose and Treatment Response Tianwei GuTing HongDalong Zhu Original Research Open access 09 March 2018 Pages: 771 - 787
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study Marco Orsini FedericiJanette McQuillanKirsi Norrbacka Original Research Open access 10 March 2018 Pages: 789 - 801
Changing Patients’ Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial Robert A. BaileyAlicia C. ShillingtonNananda Col Original Research Open access 13 March 2018 Pages: 803 - 814
Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study Xin QianHui WangGuangwei Li Original Research Open access 13 March 2018 Pages: 815 - 826
Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study Robyn K. PollomTimothy CostiganPriscilla A. Hollander Original Research Open access 14 March 2018 Pages: 827 - 837
Clinical and Cost Implications of Insulin Degludec in Patients with Type 1 Diabetes and Problematic Hypoglycemia: A Quality Improvement Project Muhammad Ali KaramatShujah DarAbd A. Tahrani Original Research Open access 16 March 2018 Pages: 839 - 849
Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions Gian Paolo FadiniMayur SarangdharAngelo Avogaro Original Research Open access 16 March 2018 Pages: 851 - 861
Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes Atsutaka YasuiGanghyuck LeeTomoo Okamura Brief Report Open access 27 February 2018 Pages: 863 - 871